Adverse events20

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 20

Type	Event	Organ system	Group	Affected	At risk
other	Visual acuity reduced	Eye disorders	Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic Solution	1	57
other	Visual acuity reduced	Eye disorders	Ketotifen Fumarate Ophthalmic Solution 0.035%	2	56
other	Visual acuity reduced	Eye disorders	Brimonidine Tartrate Ophthalmic Solution 0.025%	2	58
other	Visual acuity reduced	Eye disorders	Vehicle Ophthalmic Solution	2	56
other	Ocular hyperaemia	Eye disorders	Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic Solution	0	57
other	Ocular hyperaemia	Eye disorders	Ketotifen Fumarate Ophthalmic Solution 0.035%	2	56
other	Ocular hyperaemia	Eye disorders	Brimonidine Tartrate Ophthalmic Solution 0.025%	0	58
other	Ocular hyperaemia	Eye disorders	Vehicle Ophthalmic Solution	1	56
other	Eyelid exfoliation	Eye disorders	Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic Solution	0	57
other	Eyelid exfoliation	Eye disorders	Ketotifen Fumarate Ophthalmic Solution 0.035%	0	56
other	Eyelid exfoliation	Eye disorders	Brimonidine Tartrate Ophthalmic Solution 0.025%	0	58
other	Eyelid exfoliation	Eye disorders	Vehicle Ophthalmic Solution	1	56
other	Erythema of eyelid	Eye disorders	Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic Solution	0	57
other	Erythema of eyelid	Eye disorders	Ketotifen Fumarate Ophthalmic Solution 0.035%	0	56
other	Erythema of eyelid	Eye disorders	Brimonidine Tartrate Ophthalmic Solution 0.025%	0	58
other	Erythema of eyelid	Eye disorders	Vehicle Ophthalmic Solution	1	56
other	Conjunctival oedema	Eye disorders	Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic Solution	0	57
other	Conjunctival oedema	Eye disorders	Ketotifen Fumarate Ophthalmic Solution 0.035%	2	56
other	Conjunctival oedema	Eye disorders	Brimonidine Tartrate Ophthalmic Solution 0.025%	0	58
other	Conjunctival oedema	Eye disorders	Vehicle Ophthalmic Solution	0	56

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05591755/events

API reference For AI assistants